Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors. Zurawski J, Flinn A, Sklover L, Sloane JA J Neurol. 2016 May 18. Epub 2016 May 18. PMID: 27193310. Abstract CommentRecommendBookmarkWatch